Automation is a critical component of NGS testing and Euformatics Genomics Hub is leading the way with innovative solutions. With an ever-increasing volume and variety of data, analyzing small variants, CNVs, and structural variants in tandem is just the beginning. Other metrics like tumor mutational burden (TMB) and microsatellite instability (MSI) are becoming commonplace, and these data can be generated in a single solution or drawn from disparate systems. Synthesizing data from various sources into a single solution presents challenges, but Euformatics has the answer.

For high-throughput NGS labs, efficiency is key to profitability and sustainability. Without proper automation, pipelines can be slow, unwieldy, and inconsistent, leading to lagging profitability. Euformatics Genomics Hub tackles both consistency and efficiency with a highly modular and configurable design. Users have fine controls over each component of the pipeline and can choose which aspects are automated and how. With our latest 2.9 release of the variant interpretation tool empower users to create custom scripts to automatically produce comprehensive reports ready for review and sign-off.

Automation is not limited to clinical labs, researchers can benefit from the rapid and consistent application of NGS workflows to produce outputs like annotated VCFs or Excel spreadsheets for further curation and investigation. Euformatics variant interpretation tool nimble importer and malleable front-end allow for virtually unfettered scripting possibilities. Our secondary analysis automation scripts provide users with robust and comprehensive scripts to define and format the input to Euformatics Genomics Hub seamlessly. Euformatics provides excellent support to users getting started with this task and takes pride in implementing workflows that can be started with a single command.

In your demo session with Euformatics, you can freely evaluate their software and see firsthand how automation is a critical component of implementing NGS testing and furthering the application of precision medicine.

Back to news listing